Concepedia

Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk

Amit Khera, Brendan M. Everett, Michael P. Caulfield, Feras Hantash, Jay G. Wohlgemuth, Paul M. Ridker, Samia Mora

Circulation · 2013 · 436 citations · 30 references

DOIFull text

Open access

Abstract

http://www.clinicaltrials.gov. Unique identifier: NCT00239681.

References

30

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca et al. · New England Journal of Medicine · 2008 · 6.5K citations · Full text

Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein

Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca et al. · Obstetrical & Gynecological Survey · 2009 · 3.7K citations

, , +17

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

New England Journal of Medicine · 2011 · 2.9K citations · Full text

Lipoprotein(a) as a cardiovascular risk factor: current status

Børge G. Nordestgaard, M. John Chapman, Kausik K. Ray et al. · European Heart Journal · 2010 · 1.7K citations · Full text

Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease

Robert Clarke, John F. Peden, Jemma C. Hopewell et al. · New England Journal of Medicine · 2009 · 1.6K citations · Full text